ODI Pharma AB (publ) (NGM:ODI)
Sweden
· Delayed Price · Currency is SEK 4.360
-0.280 (-6.03%)
At close: Apr 28, 2026
ODI Pharma AB Revenue
ODI Pharma AB had revenue of 10.93M SEK in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to 20.04M, down -6.80% year-over-year. In the fiscal year ending June 30, 2025, ODI Pharma AB had annual revenue of 3.13M, down -85.94%.
Revenue (ttm)
20.04M
Revenue Growth
-6.80%
P/S Ratio
3.99
Revenue / Employee
20.04M
Employees
1
Market Cap
79.92M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mediacle Group AB | 47.49M |
| Ramlösa shipping AB | 39.45M |
| Spotlight Group AB | 114.42M |
| Amido AB | 44.95M |
| Coegin Pharma AB | 79.00K |
| GreenMerc AB | 29.16M |
| Lohilo Foods AB | 186.79M |
| Railway Metrics and Dynamics Sweden AB | 13.62M |